The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

But so far, most researchers are reassured as are regulators in the UK, United States and Europe.”Prof Sattar and Dr Cork have unpacked the side effects to be aware of:BlindnessStomach issues‘Ozempic ...